ÖZET
Amaç:
Bu araştırma ile yardımcı üreme tedavisi alan kadınların progesteron kullanımına bağlı yaşadıkları sorunların ve bunlarla baş etme yöntemlerinin belirlenmesi amaçlanmıştır.
Yöntemler:
Araştırma, 25 Temmuz-08 Ağustos 2022 tarihleri arasında bir üniversite hastanesinin infertilite polikliniğine başvuran toplam 145 kadınla yürütülmüştür. Veriler, araştırmacılar tarafından progesteron hormonu içeren ilaçların farklı formlarının kullanımına bağlı yaşanabilecek sorunları ve bunlarla baş etme yöntemlerini sorgulamaya yönelik hazırlanmış bir anket formu aracılığı ile toplanmıştır. Veriler, SPSS programında tanımlayıcı istatistikler kullanılarak değerlendirilmiştir.
Bulgular:
Kadınların yaş ortalaması 30,76±5,53 olup, evlilik süresi ortalaması 6,6±4,51 yıldı. Kadınların %64,8’i primer infertil iken %68,3’ü daha önce en az bir kez yardımcı üreme tedavisi (YÜT) almıştır. YÜT sırasında intramüsküler progesteron tedavisi alan kadınlar sıklıkla enjeksiyon bölgesinde ağrı, şişlik, apse, kızarıklık; vajinal yolla progesteron tedavisi alan kadınlar vajinal ıslaklık, ilacın vajinada kuruması, topaklanması, ilacın vücut dışına çıkması, ilacın tamamen emilmemesi, vajinal kaşıntı ve oral yolla progesteron tedavisi alan kadınlar ise halsizlik, uyku hali, bulantı, baş dönmesi, baş ağrısı, yorgunluk gibi sorunlar yaşamıştır. Kadınlar bu sorunlar ile çeşitli yöntemler kullanarak baş etmişlerdir.
Sonuç:
Araştırma YÜT alan kadınların progesteron kullanımına bağlı birçok sorun yaşadığını ve bu sorunlarla kendi yöntemleri ile baş etmeye çalıştıklarını ortaya koymuştur. Hastaların bilgilendirilmesi ve yaşanan sorunların en aza indirilmesine/giderilmesine yönelik hemşirelik girişimlerinin planlanması gerekmektedir.
References
1
The American College of Obstetricians and Gynecologist (ACOG). Treating İnfertility December 2022. Available from: https://www.acog.org/Patients/FAQs/Treating-Infertility#what (accessed date: 04.12.2022)
2
World Health Organization (WHO). Infertility 2022. Available from: https://www.who.int/health-topics/infertility#tab=tab_1 (accessed date: 04.12.2022)
3
Inhorn MC, Patrizio P. Infertility around the globe: New thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update 2015;21:411-26.
4
Infertility Workup for the Women’s Health Specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol 2019;133:377-84.
5
Yücesoy H, Akın Ö, Şahbaz G, Erbil N. Sexual function and dyadic adjustment in infertility. Androl Bul 2021;23:123-8.
6
Mesen TB. Young SL. Progesterone and the luteal phase: a requisite to reproduction. Obstet Gynecol Clin North Am 2015;42:135-51.
7
Buldum A, Güner Emül T. Treatment methods used in infertility and the role of the nurse. In: Vefikuluçay Yılmaz D, editor. Infertility Nursing 2021.p.107-27.
8
Bu Z, Yang X, Song L, Kang B, Sun Y. The impact of endometrial thickness change after progesterone administration on pregnancy outcome in patients transferred with single frozen-thawed blastocyst. Reprod Biol Endocrinol 2019;17:99.
9
Bashiri A, Halper KI, Orvieto R. Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions Reprod Biol Endocrinol 2018;16:121.
10
Hong K, Choi Y. Role of estrogen and RAS signaling in repeated implantation failure. BMB Rep 2018;51:225-9.
11
Piette PCM. The pharmacodynamics and safety of progesterone. Best Pract Res Clin Obstet Gynaecol 2020;69:13-29.
12
Işıkalan M, Ürünsak İF, Khatib G, Çetin C, Sucu M, Çetin T. Comparison of pregnancy rates with intramuscular and vaginal progesterone use for luteal phase support in intracytoplasmic sperm injection cycles. Cukurova Med J 2016;41:639-47.
13
Nasreen D. Comparative Outcome of Threatened Abortion between Patients Receiving Progesterone through Oral and Intramuscular Route. The Insight 2021;4:161-9.
14
Salehpour S, Saharkhiz N, Nazari L, Sobhaneian A, Hosseini S. Comparison of Subcutaneous and Vaginal Progesterone Used for Luteal Phase Support in Patients Undergoing Intracytoplasmic Sperm Injection Cycles. JBRA Assist Reprod 2021;25:242-5.
15
Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study. Fertil Steril 2010;94:2596-9.
16
Barbosa MWP, Valadares NPB, Barbosa ACP, Amaral AS, Iglesias JR, Nastri CO, et al. Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis. JBRA Assist Reprod 2018;22:148-56.
17
Jiang L, Luo ZY, Hao GM, Gao BL. Effects of intramuscular and vaginal progesterone supplementation on frozen-thawed embryo transfer. Sci Rep 2019;9:15264.
18
Pekcan MK, Özakşit G. Comparison of the progesterone form used in gonadotropin induced controlled ovarian stimulation-intrauterine insemination cycles and treatment efficacy. Ege Journal of Medicine 2019;58:74-7.
19
Sundström-Poromaa I, Comasco E, Sumner R, Luders E. Progesterone - Friend or foe? Front Neuroendocrinol 2020;59:100856.
20
Taş M, Uludag SZ, Aygen ME, Sahin Y. Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination. Gynecol Endocrinol 2020;36:77-80.
21
Xu H, Zhang XQ, Zhu XL, Weng HN, Xu LQ, Huang L, et al. Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle. J Gynecol Obstet Hum Reprod 2021;50:102110.
22
Vuong LN, Pham TD, Le KTQ, Ly TT, Le HL, Nguyen DTN, et al. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study. Hum Reprod 2021;36:1821-31.
23
Gencel B, Horasanlı JE, Görkemli H. The Comparison of Clinical Pregnancy Results in Patients with and Without Luteal Phase Support in luit Treatment in our Clinic Between 2016-2019. Turkish Journal of Reproductive Medicine and Surgery 2020;4:8-14.
24
Azargoon A, Joorabloo G, Mirmohammadkhani M. Luteal Phase Support in Intrauterine Insemination Cycles: A Randomized Clinical Trial of Vaginal Versus Intramuscular Progesterone Administration. J Reprod Infertil 2022;23:33-8.
25
Griesinger G, Blockeel C, Tournaye H. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard? Fertil Steril 2018;109:756-62.
26
Boelig RC, Della Corte L, Ashoush S, McKenna D, Saccone G, Rajaram S, et al. Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis. Am J Obstet Gynecol MFM 2019;1:50-62.
27
Devine K, Richter KS, Jahandideh S, Widra EA, McKeeby JL. Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial. Fertil Steril 2021;116:633-43.
28
Şahin M, Eşer İ. Effect of the buzzy application on pain and injection satisfaction in adult patients receiving intramuscular injections. Pain Manag Nurs 2018;19:645-51.
29
Çakırlı M, Açıkgöz A. Effect of CoolSense Method on Pain: Systematıc Reviews. Balıkesir Health Sciences Journal 2020;9:115-20.
30
Alaşar B, Çevik K. The Effect of Different Techniques Used in Intramuscular Injection on Pain and Drug Leakage. International Anatolia Academic Online Journal Health Sciences 2021;7:79-92.
31
Apaydın E, Öztürk H. Comparison of Intramuscular Injections Applied on Ventrogluteal and Dorsogluteal Areas in the Way of Bleeding, Pain and Hematoma. Gümüşhane University Journal of Health Sciences 2021;10:105-13.
32
Şahan S, Yıldız A. The effect of shotblocker application on intramuscular injection pain in adults: a meta-analysis. Clin Nurs Res 2022;31:820-5.
33
Ghanem ME, Al-Boghdady LA. Luteal phase support in ART: an update. In: Darwish AMM, editor. Enhancing Success of Assisted Reproduction 2012. p.155-72.
34
Merriam KS, Leake KA, Elliot M, Matthews ML, Usadi RS, Hurst BS. Sexual absorption of vaginal progesterone: a randomized control trial. Int J Endocrinol 2015;2015:685281.
35
Boelig RC, Zuppa AF, Kraft WK, Caritis S. Pharmacokinetics of vaginal progesterone in pregnancy. Am J Obstet Gynecol 2019;221:263.
36
Chi H, Li R, Qiao J, Chen X, Wang X, Hao G, et al. Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China. Eur J Obstet Gynecol Reprod Biol 2019;237:100-5.
37
Akın Ö, Şahin E. Assisted Reproductive Techniques and Nursing Approach. SAUHSD 2020;3:55-75.
38
Sarı R, Erciyes JC. Social, Psychological, and Sexual Problems of the Infertile Couples. İstanbul Kent Üniversitesi İnsan ve Toplum Bilimleri Dergisi 2021;2:79-94.
39
Zorlu S, Erbaş N. The Relationship Between Infertile Women’s Distress from Infertility, Coping With Stress, and Perceived Social Support. EGEHFD 2021;37:95-105.
40
Yılmaz G. Examination of the Roles of Nurses who Work in the Field of Infertility and the Difficulties They Experience. (Doctoral Dissertation): İzmir: Dokuz Eylül Univ. 2012.
